Cyclooxygenase-2-Dependent Expression of Angiogenic CXC Chemokines ENA-78/CXC Ligand (CXCL) 5 and Interleukin-8/CXCL8 in Human Non-Small Cell Lung Cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Research

• Publication date

  2004-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-03-3262PMID 14996749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis

  2004cited by this paper
• Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis.

  2003cited by this paper
• Chemokine-Cytokine Cross-talk

  2003cited by this paper
• Cyclooxygenase 2: a molecular target for cancer prevention and treatment.

  2003cited by this paper
• NF-κB in cancer: from innocent bystander to major culprit

  2002cited by this paper
• Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion*

  2002cited by this paper
• Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors.

  2002cited by this paper
• Hypoxia — a key regulatory factor in tumour growth

  2002cited by this paper
• Novel targets for lung cancer therapy: part I.

  2002cited by this paper
• Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury.

  2002cited by this paper
• Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.

  2002cited by this paper
• Elevated Serum Levels of Interleukin-8 in Advanced Non-Small Cell Lung Cancer Patients: Relationship with Prognosis

  2002cited by this paper
• Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.

  2002cited by this paper
• Expression of target molecules in lung cancer: challenge for a new treatment paradigm.

  2002cited by this paper
• NF-kappaB in cancer: from innocent bystander to major culprit.

  2002cited by this paper
• Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.

  2002cited by this paper
• Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.

  2001cited by this paper
• Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis

  2001cited by this paper
• IL (Interleukin)-1α Promotes Nuclear Factor-κB and AP-1-induced IL-8 Expression, Cell Survival, and Proliferation in Head and Neck Squamous Cell Carcinomas

  2001cited by this paper
• Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

  2001cited by this paper
• The intratumoral expression of vascular endothelial growth factor and interleukin‐8 associated with angiogenesis in nonsmall cell lung carcinoma patients

  2001cited by this paper
• Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis.

  2001cited by this paper
• Ischemia-Reperfusion of Rat Myocardium Activates Nuclear Factor-&kgr;B and Induces Neutrophil Infiltration Via Lipopolysaccharide-Induced CXC Chemokine

  2001cited by this paper
• IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas.

  2001cited by this paper
• Angiogenesis-dependent diseases.

  2001cited by this paper
• Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44*

  2001cited by this paper
• The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast cocultures.

  2000cited by this paper
• Level of interleukin-8 expression by metastatic human melanoma cells directly correlates with constitutive NF-kappaB activity.

  2000cited by this paper
• Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.

  2000cited by this paper
• Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung.

  2000cited by this paper
• Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer.

  2000cited by this paper
• Host cyclooxygenase-2 modulates carcinoma growth.

  2000cited by this paper
• Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.

  2000cited by this paper
• Nuclear Factor-κB Activity Correlates with Growth, Angiogenesis, and Metastasis of Human Melanoma Cells in Nude Mice

  2000cited by this paper
• The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity1

  2000cited by this paper
• Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice.

  2000cited by this paper
• Insulin-like Growth Factor-I Protects Colon Cancer Cells from Death Factor-induced Apoptosis by Potentiating Tumor Necrosis Factor α-induced Mitogen-activated Protein Kinase and Nuclear Factor κB Signaling Pathways

  2000cited by this paper
• Cyclooxygenases: structural, cellular, and molecular biology.

  2000cited by this paper
• Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer.

  2000cited by this paper
• Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

  2000cited by this paper
• Molecular Regulation of Constitutive Expression of Interleukin-8 in Human Pancreatic Adenocarcinoma

  2000cited by this paper
• Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.

  2000cited by this paper
• Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.

  2000cited by this paper
• Role of cyclooxygenases in angiogenesis.

  2000cited by this paper
• Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8.

  2000cited by this paper
• The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2*

  2000cited by this paper
• Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis1

  2000cited by this paper
• Cancer statistics, 2000

  2000cited by this paper
• CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.

  1999cited by this paper
• VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours

  1999cited by this paper
• Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer.

  1999cited by this paper
• The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression.

  1999cited by this paper
• Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer.

  1998cited by this paper
• Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

  1998cited by this paper
• Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.

  1998cited by this paper
• Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.

  1998cited by this paper
• Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

  1998cited by this paper
• Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer.

  1998cited by this paper
• Cyclooxygenase in biology and disease

  1998cited by this paper
• NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.

  1998cited by this paper
• Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.

  1998cited by this paper
• Expression of cyclooxygenase-2 in human lung carcinoma.

  1998cited by this paper
• Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

  1997cited by this paper
• Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.

  1997cited by this paper
• Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors.

  1997cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.

  1996cited by this paper
• The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor*

  1996cited by this paper
• Prostaglandin synthase 2.

  1996cited by this paper
• Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.

  1996cited by this paper
• Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production.

  1996cited by this paper
• Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.

  1996cited by this paper
• PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON‐SMALL CELL LUNG CANCER

  1996cited by this paper
• The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*)

  1995cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Microvessel count predicts metastatic disease and survival in non‐small cell lung cancer

  1995cited by this paper
• Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma

  1994cited by this paper
• The molecular biology of leukocyte chemoattractant receptors.

  1994cited by this paper
• Relation of neovascularisation to metastasis of non-small-cell lung cancer.

  1992cited by this paper
• Characterization of two high affinity human interleukin-8 receptors.

  1992cited by this paper
• Cloning of complementary DNA encoding a functional human interleukin-8 receptor.

  1991cited by this paper
• ALTERATIONS IN THE

  1985cited by this paper
• PGE2 and Angiogenesis 1

  1983cited by this paper

• Targeting neutrophils for cancer therapy

  2025cites this paper
• CXCL5 impedes CD8+ T cell immunity by upregulating PD-L1 expression in lung cancer via PXN/AKT signaling phosphorylation and neutrophil chemotaxis

  2024cites this paper
• CXCL5 expression is associated with active signals of macrophages in the microenvironment of papillary thyroid carcinoma.

  2024cites this paper
• Paracrine Regulation and Immune System Pathways in the Inflammatory Tumor Microenvironment of Lung Cancer: Insights into Oncogenesis and Immunotherapeutic Strategies

  2024cites this paper
• Characterization of genomic instability-related genes predicts survival and therapeutic response in lung adenocarcinoma

  2023cites this paper
• Overview of G-protein coupled receptors (GPCRs) in adipose tissues and their regulatory roles in the pathophysiology of human diseases

  2023cites this paper
• The Role of CXC Chemokines in Cancer Progression

  2022cites this paper
• circDHTKD1 promotes lymphatic metastasis of bladder cancer by upregulating CXCL5

  2022cites this paper
• Role of inflammation and pro-inflammatory cytokine IL-1β in pathogenesis and metastasis of lung cancer (review)

  2021cites this paper
• Transcriptome Analysis Reveals the Differential In�ammatory Effects Between Propofol and Sevo�urane During Lung Cancer Resection: a Randomized Pilot Study

  2021cites this paper
• Regulation of inflammation and COX-2 gene expression in benzo (a) pyrene induced lung carcinogenesis in mice by all trans retinoic acid (ATRA).

  2021cites this paper
• Transcriptome analysis reveals the differential inflammatory effects between propofol and sevoflurane during lung cancer resection: a randomized pilot study

  2021cites this paper
• Bioinformatics Analyses Reveals a Comprehensive Landscape of CXC Chemokine Family Functions in Non-Small Cell Lung Cancer

  2021cites this paper
• Identification of key pathways and genes shared between Crohn's disease and breast cancer using bioinformatics analysis

  2020cites this paper
• The Emerging Role of PPAR Beta/Delta in Tumor Angiogenesis

  2020cites this paper
• Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer

  2020cites this paper
• The Role of Interleukin 1β in the Pathogenesis of Lung Cancer

  2020cites this paper
• G Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers

  2020cites this paper
• CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target

  2020cites this paper
• The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma

  2020cites this paper
• NF-κB inhibitors in treatment and prevention of lung cancer.

  2020cites this paper
• High CXCR2 expression predicts poor prognosis in adult patients with acute myeloid leukemia

  2020cites this paper
• Interleukin-8 promotes prostate cancer bone metastasis through upregulation of bone sialoprotein

  2019cites this paper
• Myeloid-derived suppressor cell-dependent inhibition of B cell responses in non-small cell lung cancer.

  2019cites this paper
• Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases.

  2019cites this paper
• Expression of CXCL5 Gene in Patients Suffering from Non-Small Cell Lung Cancer

  2019influential citation
• Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment

  2019cites this paper
• Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy

  2019cites this paper
• Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization

  2018cites this paper
• CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells

  2018cites this paper
• The clinical significance of CXCL5 in non-small cell lung cancer

  2017cites this paper
• Natural Products Targeting Clinically Relevant Enzymes of Eicosanoid Biosynthesis Implicated in Inflammation and Cancer

  2017cites this paper
• CXCL5 secreted from adipose tissue-derived stem cells promotes cancer cell proliferation

  2017cites this paper
• The clinical significance of CXCL 5 in non-small cell lung cancer

  2017cites this paper
• Cancer and inflammation

  2017cites this paper
• Interrelation of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells

  2016influential citation
• β-Elemonic acid inhibits the cell proliferation of human lung adenocarcinoma A549 cells: The role of MAPK, ROS activation and glutathione depletion.

  2016cites this paper
• The CXCL8-CXCR1/2 pathways in cancer

  2016cites this paper
• Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: An Update.

  2016cites this paper
• Secretion of wound healing mediators by single and bi-layer skin substitutes

  2016cites this paper
• Thrombin receptor PAR-1 activation on endothelial progenitor cells enhances chemotaxis-associated genes expression and leukocyte recruitment by a COX-2-dependent mechanism

  2015cites this paper
• Inflammation and the Migration of Mesenchymal Stem Cell

  2015cites this paper
• Randomized phase 2 trial of erlotinib in combination with high‐dose celecoxib or placebo in patients with advanced non‐small cell lung cancer

  2015cites this paper
• Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma

  2014cites this paper
• Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.

  2014cites this paper
• Human Lung Cancer Cells Confer Cannabidiol-Induced Apoptosis of γ

  2014cites this paper
• Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features

  2014cites this paper
• Interleukin-10 Superfamily and Cancer

  2014cites this paper
• CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors

  2014cites this paper
• An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases.

  2013cites this paper
• Les thérapies anti-angiogéniques : entre espoir et réalité. Vers l'identification de marqueurs prédictifs et de nouvelles cibles thérapeutiques dans le traitement du cancer du rein

  2013cites this paper
• Cancer Therapeutic Insights COX-2 and PPAR-g Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells

  2013cites this paper
• CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model

  2013cites this paper
• Slug induces malignant phenotypes in models of human lung premalignancy

  2013cites this paper
• Chapter The Role of Cyclooxygenases and Lipoxygenases in the Regulation of Tumor Angiogenesis

  2013cites this paper
• Investigating c-Met Signaling in Non-Small Cell Lung Cancer

  2012cites this paper
• Investigating c-Met Signaling in Non-Small Cell Lung Cancer

  2012cites this paper
• Smoking and Lung Cancer

  2012cites this paper
• EMERGING ROLE OF CXCL 8 IN SQUAMOUS CELL LUNG CARCINOMA *

  2012cites this paper
• Alteration in Metastasis Potential and Gene Expression in Human Lung Cancer Cell Lines by ITGB8 Silencing

  2012cites this paper
• The Inflammatory Tumor Microenvironment, Epithelial Mesenchymal Transition and Lung Carcinogenesis

  2012cites this paper
• Cancer Cell Signaling Pathways Targeted by Spice-Derived Nutraceuticals

  2012cites this paper
• COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells

  2012cites this paper
• Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy

  2012cites this paper
• Identification of CXCL5/ENA‐78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer‐associated fibroblasts

  2012cites this paper
• Multifaceted link between cancer and inflammation.

  2012cites this paper
• Interleukin‐8 derived from local tissue‐resident stromal cells promotes tumor cell invasion

  2012cites this paper
• Differential apoptotic effects of novel quinuclidinone analogs 8a and 8b in normal and lung cancer cell lines.

  2011cites this paper
• Role of Inflammation in Cancer Development

  2011cites this paper
• Evolving Concepts in Lung Carcinogenesis

  2011cites this paper
• PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.

  2011cites this paper
• Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs

  2011cites this paper
• EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features

  2011cites this paper
• Tumor microenvironment is multifaceted

  2011cites this paper
• TITLE: Molecular Profiles for Lung Cancer Pathogenesis and Detection in US Veterans

  2011cites this paper
• Evolving concepts in lung carcinogenesis.

  2011cites this paper
• Molecular Profiles for Lung Cancer Pathogenesis and Detection in U.S. Veterans

  2011cites this paper
• Studies of the tumor microenvironment : Local and systemic effects exerted by the cross-talk between tumor and stroma cells in pancreatic cancer

  2010cites this paper
• Neutralizing endogenous chemokines with small molecules

  2010cites this paper
• Nucleotide‐binding domain of phosphoglycerate kinase 1 reduces tumor growth by suppressing COX‐2 expression

  2010cites this paper
• 3,3′‐diindolylmethane suppresses 12‐O‐tetradecanoylphorbol‐13‐acetate‐induced inflammation and tumor promotion in mouse skin via the downregulation of inflammatory mediators

  2010cites this paper
• Knockout of the Tumor Suppressor Gene Gprc5a in Mice Leads to NF-κB Activation in Airway Epithelium and Promotes Lung Inflammation and Tumorigenesis

  2010cites this paper
• Improvement of methodology to study ICAM-1 and CXCL-5 expressions of ambient particles, in vitro

  2010influential citation
• Bustle behind the scenes of action: nemosis as a model for fibroblast inflammatory activation

  2010cites this paper
• Immunologic Mechanisms in Lung Carcinogenesis and Metastasis

  2009cites this paper
• Amplification of Lipopolysaccharide-Induced Cytokine Synthesis in Non–Small Cell Lung Cancer/Neutrophil Cocultures

  2009cites this paper
• N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression.

  2009cites this paper
• Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.

  2009influential citation
• Eicosanoids in inflammation and cancer: the role of COX-2

  2009cites this paper
• Prostaglandin E2 receptor 2 overexpression in squamous cell carcinoma of the lung correlates with p16INK4A methylation and an unfavorable prognosis.

  2009cites this paper
• Serum-Free Medium Evokes Cyclooxygenase-2 Pathway in A549 Cells

  2009cites this paper
• Clustering of fibroblasts induces proinflammatory chemokine secretion promoting leukocyte migration.

  2009cites this paper
• IL-27 Directly Restrains Lung Tumorigenicity by Suppressing Cyclooxygenase-2-Mediated Activities1

  2009cites this paper
• Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12

  2009cites this paper
• Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis.

  2009cites this paper
• Cyclooxygenase-2-Mediated Activities Tumorigenicity by Suppressing IL-27 Directly

  2009cites this paper
• Nickel and the microbial toxin, MALP-2, stimulate proangiogenic mediators from human lung fibroblasts via a HIF-1alpha and COX-2-mediated pathway.

  2009cites this paper
• CXC Chemokines in Cancer Angiogenesis

  2009cites this paper
• Chemokines in Lung Cancer Metastasis

  2009cites this paper
• Cell Adhesion Molecules

  2009cites this paper